PART I Overview Axim Biotechnologies, Inc., a Nevada corporation, is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axims core competencies include develop...
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-04-16 | 2023-12-31 | 0001096906-24-000864 | EDGAR | 54K words |
| 2023-04-17 | 2022-12-31 | 0001096906-23-000858 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001096906-22-000886 | EDGAR | — |
| 2021-04-15 | 2020-12-31 | 0001078782-21-000365 | EDGAR | — |
| 2020-05-14 | 2019-12-31 | 0001078782-20-000331 | EDGAR | — |
| 2019-04-08 | 2018-12-31 | 0001078782-19-000304 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001078782-18-000306 | EDGAR | — |
| 2017-04-17 | 2016-12-31 | 0001078782-17-000498 | EDGAR | — |
| 2016-04-14 | 2015-12-31 | 0001387308-16-000187 | EDGAR | — |
| 2015-04-14 | 2014-12-31 | 0001387308-15-000034 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-08-19 | 2024-06-30 | 0001096906-24-001772 | EDGAR | 43K words |
| 2024-05-20 | 2024-03-31 | 0001096906-24-001202 | EDGAR | — |
| 2023-11-20 | 2023-09-30 | 0001096906-23-002238 | EDGAR | — |
| 2023-08-21 | 2023-06-30 | 0001096906-23-001655 | EDGAR | — |
| 2023-05-22 | 2023-03-31 | 0001096906-23-001168 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001096906-22-002767 | EDGAR | — |
| 2022-08-16 | 2022-06-30 | 0001096906-22-001922 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001096906-22-001257 | EDGAR | — |
| 2021-11-22 | 2021-09-30 | 0001096906-21-002816 | EDGAR | — |
| 2021-08-23 | 2021-06-30 | 0001096906-21-002137 | EDGAR | — |
| 2021-05-24 | 2021-03-31 | 0001078782-21-000487 | EDGAR | — |
| 2020-11-20 | 2020-09-30 | 0001078782-20-000900 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2024-10-15 | 0001096906-24-002002 | EDGAR | 1K words |
| 2024-03-21 | 0001096906-24-000539 | EDGAR | — |
| 2024-02-13 | 0001096906-24-000199 | EDGAR | — |
| 2023-12-28 | 0001096906-23-002456 | EDGAR | — |
| 2023-06-02 | 0001096906-23-001228 | EDGAR | — |
| 2023-05-30 | 0001096906-23-001206 | EDGAR | — |
| 2023-05-25 | 0001096906-23-001188 | EDGAR | — |
| 2023-01-27 | 0001096906-23-000219 | EDGAR | — |
| 2022-09-19 | 0001096906-22-002280 | EDGAR | — |
| 2022-08-29 | 0001096906-22-002035 | EDGAR | — |
154 total filings indexed. 122 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001514946 |
| Ticker | AXIM |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report